• Fertility preservation first, treatment second

    A germinal cell tumour is diagnosed. What's next? Sonography, tumour markers, and also cryopreservation? Before you start oncological therapy, you help your patient to fulfill a future wish to have children.

  • Epilepsy: Encouraging Mothers under Anticonvulsant Therapy to Breastfeed

    Breastfeeding while taking antiepileptic drugs is a topic that is discussed time and again. New study findings once again speak in favour of breastfeeding from a neurological point of view.

  • Lung Cancer and Biomarkers: Facilitating Diagnostics of Pulmonary Nodules

    A new combined biomarker model could help avoid unnecessary biopsies and shorten the time to diagnosis in malignant lesions.

  • Is there a vaccine against toxoplasmosis?

    If you search the internet for a toxoplasmosis vaccine, you will simply get the answer: "There is no vaccine against toxoplasmosis". This could change in the future.

  • How minor vascular tone changes maintain high retinal performance

    The retina is one of the organs with the highest metabolic activity. Maintaining a high performance operation requires the ocular microvasculature to support the retina.

  • Chronic traumatic encephalopathy: Earlier diagnosis for a better quality of life

    Until now, the diagnosis of CTE could only be confirmed at autopsy but a recent study may have found MRI markers to identify CTE during a patient's lifetime.

  • Opioids: The rise and fall of the Sackler family

    "No one has impacted the very nature of medical marketing more than the multi-talented Dr. Arthur Sackler," says the Medical Advertising Hall of Fame about the man whose family name is now synonymous with the opioid epidemic.

  • On the disappearance of normal weight among young people

    The average young adult in the USA is now overweight. An alarming evaluation.

  • Antibiotics in early childhood could affect brain development

    Early exposure to penicillins could alter human brain development in areas responsible for cognitive and emotional functions.

  • Case vignette: Acute iatrogenic complication with diabetes

    A recent case report of a young type 1 diabetic man published in the British Medical Journal is a reminder of an important clinical finding and a picture of what may be more common than previously thought....

  • The dark side of sun screens: Carcinogens in many products

    Good sun protection reduces the risk of sunburn and skin cancer. However, products that contain toxic ingredients should not be part of these preventive measures.

  • Colorectal cancer: Defying genetics

    For people at high genetic risk of colorectal cancer, lifestyle changes have a particularly strong impact, study finds.

  • Neurobehavioural therapy for glaucoma using citicoline

    Other factors besides intraocular pressure must exist that influence the success of glaucoma therapy. A recently published scientific study has dealt with exactly this topic.

  • Parkinson's disease: When will the fog clear?

    Parkinson's disease is the fastest growing neurological disorder worldwide. An increasing number of studies are also looking at environmental factors that could plausibly have contributed to the rapid increase.

  • The role of cell death in COPD

    Targeted inhibition of necroptosis could be a promising new approach to treating chronic obstructive pulmonary disease (COPD).

  • Factory farming, climate change, modern lifestyles and zoonoses

    Influenza A viruses are in a constant state of evolution and their zoonotic potential puts immunologists worldwide on high alert.

  • Optogenetics illuminates darkness

    Using optogenetics, a 58-year-old man with advanced retinitis pigmentosa, who was blind in one eye, was able to perceive light in that eye after treatment.

  • Aducanumab: A medication causes a stir (Part II)

    The FDA approval of an anti-amyloid antibody made waves, and let to a shake-up of it´s expert committee. Here´s a sequel to the analysis on the events as they unfolded.

  • Is lack of sleep the elephant in the room?

    In a 9-year study, type 2 diabetics who regularly suffered from sleep problems had an 87% higher risk of death compared to people without diabetes or sleep problems.

  • Aducanumab: It got a fast-track approval after all. So what was going on? (Part I)

    The FDA has approved the controversial Alzheimer's drug after all, even against the recommendation of its own advisory committee; and three of its members have since left.

  • 1 |
  • 2 |
  • 3 |
  • 4 |
  • 5 |
  • 6 |
  • 7 |
  • 8 |